about
Atrial tachycardia ablation in a patient with double outlet right ventricle corrected by surgery.Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.Diaphragmatic myopotential oversensing in pacemaker-dependent patients with CRT-D devices.Prognostic Value of a Very Prolonged Asystole during Head-Up Tilt Test.Natural history of Brugada syndrome in a patient with congenital heart disease.[Value of "cardiac event recorders" in the assessment of sporadic cardiac symptoms][Syncope in a patient with Ebstein's anomaly and Wolff-Parkinson-White syndrome]Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data.Low bone volume--a risk factor for coronary calcifications in hemodialysis patientsLeadless Pacemaker: a New Concept in Cardiac Pacing.Cardiac Resynchronization Therapy in Patients with Atrial Fibrillation - Worth the Effort?MRI-conditional pacemakers: current perspectives.Adenosine-guided pulmonary vein isolation versus conventional pulmonary vein isolation in patients undergoing atrial fibrillation ablation: An updated meta-analysis.Safety and Long-Term Outcomes of Catheter Ablation of Atrial Fibrillation Using Magnetic Navigation versus Manual Conventional Ablation: A Propensity-Score Analysis.Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study.Five years of catheter ablation procedures in South-Western Europe: meta-analysis of National Registries.Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator.National Registry on Cardiac Electrophysiology 2009.A rare case of persistent troponin elevation in a patient with chronic heart failure.Remote magnetic navigation for mapping and ablation of right and left ventricular outflow tract arrhythmias.A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients.An anomalous trajectory of a defibrillation lead.Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure - ATLAS score.Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD: design and rationale of the EFFORTLESS S-ICD Registry.Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.Load-independent parameters of diastolic and systolic function by speckle tracking and tissue doppler in hemodialysis patients.Brugada syndrome is associated with scar and endocardial involvement: Insights from high-density mapping with the Rhythmia™ mapping system.Left atrial volume is more important than the type of atrial fibrillation in predicting the long-term success of catheter ablation.National Registry on Cardiac Electrophysiology--2004.Coronary sinus pacing in a patient with a tricuspid prosthesis.Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation-the protective role of antiarrhythmic drug therapy.Cardiac resynchronization therapy: can left ventricular lead position make the difference?Incidence, determinants, and prognostic implications of true pleomorphism of ventricular tachycardia in patients with implantable cardioverter-defribillators: a substudy of the DATAS Trial.National Registry on Cardiac Electrophysiology--2003.Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure: ATLAS score-Author's reply.Characterization of pulmonary vein morphology using multi-detector row CT study prior to radiofrequency ablation for atrial fibrillation.Non-calcium-containing phosphate binders: comparing efficacy, safety, and other clinical effectsAblação epicárdica percutânea em arritmias ventriculares
P50
Q33151322-D6538A0C-15BB-4593-81EA-0A21784E2C24Q33152752-C106D8C5-ADE9-4E2E-AE02-F3FD350C3903Q33156602-EE4C263F-BF7E-4315-BCB5-F1AA01472E0BQ33165691-33DA249E-36F9-4AD6-BC24-69171D58EE29Q33165979-8AFCB525-532F-475A-A100-2D93C1056BBCQ33175512-C2AB06BE-0507-4A2C-8F37-E4B5C3EDD90CQ33175665-29A7B5A4-F5BE-4518-808F-8D81DD03AB1CQ33387235-303CF380-F30D-491E-B21C-EA2D038E978CQ37087934-0A7EB2A8-99FF-4E0B-98BA-8CEC52F95554Q37404290-E4019569-3409-43D0-9CC5-049A7CE6B33AQ37496196-6C88C395-FD5C-419F-9E29-F0D335FFF198Q38213706-CD3E8EA5-5B14-485A-9D19-7C5E910C7E21Q39174177-6D8AFFF9-5BA7-4B9F-B358-3F86D9A83B52Q40858272-377C0CEF-3ABF-444C-8192-363D42E84E16Q42968608-CD821DD7-6F93-4D54-8097-5D83A1776323Q43605665-69960A7A-DE69-4A49-8EA4-F8403C2DA7F8Q43628055-B6876D5D-44A4-4EE4-8EA3-C539C497AAABQ44294686-F471D345-0C97-4F86-91CD-257424483D86Q44336691-0EDD646C-E5ED-44B4-8601-F4BE176A8676Q44587188-F2B5AD84-8CBF-41EB-A9DD-00AD7C617CA9Q45331070-D658D154-6BFA-4B7F-8567-9F8077817D6AQ46294917-D6615279-E28D-435E-A4D8-842680BCBA0FQ47591410-6FE3B6E1-E7B6-4132-9853-1E77674D47C3Q47615006-F0883827-06A4-4F59-B7BE-E5962F867455Q48013239-44A96ED8-C570-407C-9B8F-84C1C66FB6C5Q48477901-4E55587D-B837-4707-8AA7-AC3A8BA6DDD8Q48624138-A8162630-E0B5-4889-ADD9-126CF4D92AFEQ48867753-096577F5-3D80-4845-8B72-E2873BB055F1Q50098980-713A9D7B-5DF4-4B83-8B05-0E5C3EE5222BQ51053590-81D3F9DD-7F1D-4608-8B77-919AC285328DQ51175779-A33105BA-1843-4B3F-9DB8-ED73AF30B31EQ51275226-13277C1B-DC91-4C68-A7CF-8ABE6B7F10F0Q51411747-46C0D960-0DBD-4EC1-9F50-31E05BBF3B90Q51513103-D029FC53-BF7D-4E05-9C78-26AD7CBFD332Q51532794-F690A7A0-CFAE-472C-A307-0FA2FC63B316Q51544209-88A57363-7343-44A4-AB19-2191A8A69AE9Q52648696-288C5031-9C88-4D96-931F-56344B5D06E4Q53341125-0CB784F6-1ADE-4500-912E-31F950829D82Q57219101-DD750FB2-CBD4-4D24-B0F0-5AABD12E9A64Q58757311-DEA17971-2770-4CB3-A7C4-4F810B48680C
P50
description
researcher ORCID ID = 0000-0003-3729-3137
@en
wetenschapper
@nl
name
Pedro Adragao
@ast
Pedro Adragao
@en
Pedro Adragao
@es
Pedro Adragao
@nl
Pedro Adragão
@pt
type
label
Pedro Adragao
@ast
Pedro Adragao
@en
Pedro Adragao
@es
Pedro Adragao
@nl
Pedro Adragão
@pt
altLabel
Pedro Manuel Pulido Garcia Adragão
@pt
prefLabel
Pedro Adragao
@ast
Pedro Adragao
@en
Pedro Adragao
@es
Pedro Adragao
@nl
Pedro Adragão
@pt
P1153
7003991651
P21
P31
P496
0000-0003-3729-3137